Viking Therapeutics Inc. logo

Viking Therapeutics Inc. (0VQA)

Market Closed
3 Jun, 15:30
LSE LSE
$
29. 32
-0.43
-1.45%
$
- Market Cap
- P/E Ratio
- Div Yield
9,066 Volume
-0.92 Eps
$ 29.75
Previous Close
Add Transaction
Day Range
28.62 29.88
Year Range
23.09 59.06
Want to track 0VQA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Viking Therapeutics Inc. logo
0VQA Viking Therapeutics Inc.
21 Apr 2026
-
-
Viking Therapeutics Inc. logo
0VQA Viking Therapeutics Inc.
4 Feb 2026
-
-
Viking Therapeutics Inc. logo
0VQA Viking Therapeutics Inc.
21 Oct 2025
-
-
Viking Therapeutics Inc. logo
0VQA Viking Therapeutics Inc.
22 Jul 2025
-
-

0VQA Earnings Reports FAQ

What is the earnings per share (EPS) for 0VQA?

The current EPS is -0.92.

What is the company's earnings growth rate?

Viking Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Viking Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Viking Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0VQA at this time, as Viking Therapeutics Inc has no recent EPS data to calculate it.